These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31319789)

  • 21. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
    Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
    Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparing for pragmatic trials in dementia care: Health equity considerations for nonpharmacological interventions.
    Aranda MP; Baier R; Hinton L; Peak KD; Jackson JD; Dilworth-Anderson P; Gitlin LN; Jutkowitz E; Quiñones AR
    J Am Geriatr Soc; 2023 Dec; 71(12):3874-3885. PubMed ID: 37656062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethics and Collateral Findings in Pragmatic Clinical Trials.
    Morain SR; Weinfurt K; Bollinger J; Geller G; Mathews DJ; Sugarman J
    Am J Bioeth; 2020 Jan; 20(1):6-18. PubMed ID: 31896322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
    Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
    Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meeting pragmatism halfway: making a pragmatic clinical trial protocol.
    Rushforth A
    Sociol Health Illn; 2015 Nov; 37(8):1285-98. PubMed ID: 26235211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pragmatic Trials in Genomic Medicine: The Integrating Pharmacogenetics In Clinical Care (I-PICC) Study.
    Brunette CA; Miller SJ; Majahalme N; Hau C; MacMullen L; Advani S; Ludin SA; Zimolzak AJ; Vassy JL
    Clin Transl Sci; 2020 Mar; 13(2):381-390. PubMed ID: 31808996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protecting seriously ill populations during pragmatic clinical trials.
    Teno JM; Hanson LC; Lima JC; Saliba D
    J Am Geriatr Soc; 2023 Jul; 71(7):2290-2296. PubMed ID: 36949574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applying the pragmatic-explanatory continuum indicator summary to the implementation of a physical activity coaching trial in chronic obstructive pulmonary disease.
    Nguyen HQ; Moy ML; Fan VS; Gould MK; Xiang A; Bailey A; Desai S; Coleman KJ
    Nurs Outlook; 2018 Sep; 66(5):455-463. PubMed ID: 30144938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pragmatic clinical trials offer unique opportunities for disseminating, implementing, and sustaining evidence-based practices into clinical care: Proceedings of a workshop.
    Tuzzio L; Larson EB; Chambers DA; Coronado GD; Curtis LH; Weber WJ; Zatzick DF; Meyers CM
    Healthc (Amst); 2019 Mar; 7(1):51-57. PubMed ID: 30594497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is this study feasible? Facilitating management of pragmatic trial planning milestones under a phased award funding mechanism.
    Lipman PD; Dluzak L; Stoney CM
    Trials; 2019 May; 20(1):307. PubMed ID: 31146778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development, acceptability, appropriateness and appeal of a cancer clinical trials implementation intervention for rural- and minority-serving urology practices.
    Ellis S; Geana M; Griebling T; McWilliams C; Gills J; Stratton K; Mackay C; Shifter A; Zganjar A; Thrasher B
    Trials; 2019 Oct; 20(1):578. PubMed ID: 31590694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pragmatic trials in long-term care: Challenges, opportunities, recommendations.
    Levy C; Zimmerman S; Mor V; Gifford D; Greenberg SA; Klinger JH; Lieblich C; Linnebur S; McAllister A; Nazir A; Pace D; Stone R; Resnick B; Sloane PD; Ouslander J; Gaugler JE
    Geriatr Nurs; 2022; 44():282-287. PubMed ID: 35219533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol.
    Nicholls SG; Carroll K; Brehaut J; Weijer C; Hey SP; Goldstein CE; Zwarenstein M; Graham ID; McKenzie JE; McIntyre L; Jairath V; Campbell MK; Grimshaw JM; Fergusson DA; Taljaard M
    BMC Med Ethics; 2018 Nov; 19(1):90. PubMed ID: 30458809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory.
    Johnson KE; Neta G; Dember LM; Coronado GD; Suls J; Chambers DA; Rundell S; Smith DH; Liu B; Taplin S; Stoney CM; Farrell MM; Glasgow RE
    Trials; 2016 Jan; 17():32. PubMed ID: 26772801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Form follows function: pragmatic controlled trials (PCTs) have to answer different questions and require different designs than randomized controlled trials (RCTs).
    Porzsolt F; Eisemann M; Habs M; Wyer P
    Z Gesundh Wiss; 2013 Jun; 21(3):307-313. PubMed ID: 23687408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pragmatic Trials in Long-Term Care: Implementation and Dissemination Challenges and Opportunities.
    Levy C; Zimmerman S; Mor V; Gifford D; Greenberg SA; Klinger JH; Lieblich C; Linnebur S; McAllister A; Nazir A; Pace D; Stone R; Resnick B; Sloane PD; Ouslander J; Gaugler JE
    J Am Geriatr Soc; 2022 Mar; 70(3):709-717. PubMed ID: 35195281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of research.
    Gaglio B; Phillips SM; Heurtin-Roberts S; Sanchez MA; Glasgow RE
    Implement Sci; 2014 Aug; 9():96. PubMed ID: 25163664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the design and reporting of pragmatic trials in osteoarthritis research.
    Ali SA; Kloseck M; Lee K; Walsh KE; MacDermid JC; Fitzsimmons D
    Rheumatology (Oxford); 2018 Jan; 57(1):59-63. PubMed ID: 28371879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.